Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage.
The Lancet Global Health · 2017-10-30 · Guideline / consensus
Abstract
No abstract available.
Tags
Haemostatics · Time intervals · Tranexamic acid · Mortality & survival · Pregnant patients
Related articles
- Tranexamic acid versus oxytocin for primary postpartum Haemorrhage in the out-of-hospital setting: A systematic review with implications for rural practice. (Aust J Rural Health, 2024)
- Treatment for primary postpartum haemorrhage. (Cochrane Database Syst Rev, 2014)
- Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (Lancet, 2017)
- Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. (Transfusion, 2014)
- Effects of tranexamic acid treatment in severely and non-severely injured trauma patients. (Transfusion, 2022)
- Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials. (J Matern Fetal Neonatal Med, 2020)